Panel Discussion: Building Sustainable CAR-T Access Through Community Oncology Engagement
- Why community oncology is critical to scaling CAR-T and building infrastructure for long-term patient access
- Key operational and financial differences between academic and community sites that impact market entry
- How reimbursement timelines, coverage policies, and financial risk influence community adoption of high-cost cell therapies